Table 2.
Summary of longitudinal health data collectiona
| All subjects (n=58) | Atopy statusb | ||
|---|---|---|---|
| Allergic (n=42) | Nonallergic (n=16) | ||
|
| |||
| Percent of interviews in which each symptom reported: | |||
| Woken by asthma | 45.4% | 51.5% | 27.8% |
| Limited in daily activities | 19.6% | 21.5% | 14.1% |
| Shortness of breath | 34.8% | 38.2% | 24.9% |
| Symptoms in morning | 38.7% | 42.7% | 27.0% |
| Wheezing | 24.5% | 28.9% | 21.7% |
| Percent of interviews in which puffs of bronchodilator reported | 50.7% | 55.3% | 37.4% |
| Subject average FEV1, % predicted | 75 +/− 15% | 75 +/− 16% | 76 +/− 11% |
Abbreviations; FEV1%, forced expiratory volume in 1 second as a percent of predicted value.
a
Continuous values presented as mean +/− standard deviation and categorical results as percent of responses.
b
Indicated by positive skin prick test to at least one of 22 common inhalant allergens.